44
Views
0
CrossRef citations to date
0
Altmetric
Meeting Report

Quality of life in cancer clinical trials: researchers, patients and policy makers

Pages 661-665 | Published online: 09 Jan 2014

References

  • Bottomley A, Therasse P, Piccart M et al. Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled Phase III trial. Lancet Oncol.6(5), 287–294 (2005).
  • Velikova G, Booth L, Smith AB et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J. Clin. Oncol.22(4), 714–724 (2004).
  • Quinten C, Coens C, Mauer M et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol.10(9), 865–871 (2009).
  • Goldberg RM, Sargent DJ, Morton RF et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J. Clin. Oncol.22(1), 23–30 (2004).
  • Au H-J, Ringash J, Brundage M, Palmer M, Richardson H, Meyer RM. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. Expert Rev. Pharmacoecon. Outcomes Res.10(2), 119–128 (2010).
  • O’Sullivan B, Davis AM, Turcotte R et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet359(9325), 2235–2241 (2002).
  • Bottomley A, Coens C, Suciu S et al. Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a Phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. J. Clin. Oncol.27(18), 2916–2923 (2009).
  • Fitzsimmons D, Gilbert J, Howse F et al. A systematic review of the use and validation of health-related quality of life instruments in older cancer patients. Eur. J. Cancer45(1), 19–32 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.